|
TMEM164 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
9.34520016926399E-10 |
| Normal-vs-Stage3 |
1.3426999956323E-08 |
| Normal-vs-Stage4 |
7.58600000000387E-05 |
| Stage1-vs-Stage2 |
1.670820E-01 |
| Stage1-vs-Stage3 |
1.539960E-01 |
| Stage1-vs-Stage4 |
3.263600E-01 |
| Stage2-vs-Stage3 |
7.725000E-01 |
| Stage2-vs-Stage4 |
6.270400E-01 |
| Stage3-vs-Stage4 |
8.116800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
2.99760216648792E-15 |
| Normal-vs-Asian |
2.39229999998702E-06 |
| Caucasian-vs-AfricanAmerican |
7.554000E-01 |
| Caucasian-vs-Asian |
6.547200E-01 |
| AfricanAmerican-vs-Asian |
6.095400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
2.95919955206614E-10 |
| Male-vs-Female |
6.48859999999862E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.63624669369256E-12 |
| Normal-vs-Extreme_Weight |
1.99840144432528E-15 |
| Normal-vs-Obese |
1.922240144836E-12 |
| Normal-vs-Extreme_Obese |
3.12120000001137E-06 |
| Normal_Weight-vs-Extreme_Weight |
2.781800E-01 |
| Normal_Weight-vs-Obese |
2.294200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.677000E-01 |
| Extreme_Weight-vs-Obese |
8.215800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.621000E-01 |
| Obese-vs-Extreme_Obese |
8.966800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.50580000024547E-07 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
3.37149996809671E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.479210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.795700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.294400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.120000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.447800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.857000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.64301905414277E-12 |
| Normal-VS-Type2 PRCC |
4.77395900588817E-15 |
| Normal-VS-KIRP CIMP |
2.150100E-02 |
| Normal-VS-Unclassified PRCC |
1.86961557346876E-12 |
| Type1 PRCC-VS-Type2 PRCC |
4.485000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.700800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.143000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.219100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.402800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.536560E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62880819942757E-12 |
| Normal-vs-N1 |
5.93150000005593E-07 |
| Normal-vs-N2 |
2.957200E-01 |
| N0-vs-N1 |
1.915950E-02 |
| N0-vs-N2 |
1.632440E-01 |
| N1-vs-N2 |
1.587160E-01 |
|
|
